Search results
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via AOL· 1 hour ago(NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division...
Moderna wins patent case in Europe against Pfizer, BioNTech over COVID shot
Reuters· 3 hours agoModerna said that the European Patent Office had decided to maintain the validity of one of the...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 10 hours agoThe Sanofi agreement even prompted Novavax to say it now no longer is at risk of shutting its doors. But does this mean Novavax could become a leader in...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
AOL· 4 hours ago"We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna's EP949 patent, one of the key patents currently asserted against Pfizer ...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 1 day agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks· 15 hours ago(FULC Quick QuoteFULC - Free Report) , Moderna, Inc. (MRNA Quick QuoteMRNA - Free Report) and Bristol Myers (BMY Quick QuoteBMY - Free Report) .
Moderna director Noubar Afeyan sells over $1.8m in company stock By Investing.com
Investing.com· 7 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has recently sold a significant amount of...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy? | The Motley Fool
The Motley Fool· 5 days agoModerna (MRNA -4.38%) and OpenAI are collaborating to bring artificial intelligence (AI) to every...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 3 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
NBC Securities Inc. Raises Stake in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 13 hours agoNBC Securities Inc. grew its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 20.2% during the 4th quarter, according to the company in its most recent 13F filing ...
